Breaking news on life science and diagnostics business, policy, and funding
The firm aims to offer a clinical service next year for predicting immunotherapy response and adverse immune reactions.
MedTek21's software is designed to continuously analyze patient records to provide real-time personalized medication reports to physicians.
The firm said that its system combines many of the analytical strengths of a higher-volume instrument with the ease of a table-top analyzer.
The firm said that it expects to log $500 million in revenues from its Alere rapid diagnostics business in the second quarter.
The firms will work to accelerate the adoption of PierianDx's genomics platform for translating data into patient-specific diagnoses and treatments.